이노비바(Innoviva)
DE ˙ DB ˙ US45781M1018
€19.20 ↑0.70 (3.78%)
2026-06-04
주가
SecurityDE:HVE / Innoviva, Inc.
InstitutionVanguard Group Inc
Latest Disclosed Ownership0 shares
Ownership 0.00%
Vanguard Group Inc ownership in HVE / Innoviva, Inc.

2026-03-27 - Vanguard Group Inc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Innoviva, Inc. (DE:HVE). This represents 0.0 percent ownership of the company. In their previous filing dated 2024-02-13 , Vanguard Group Inc had reported owning 6,712,443 shares, indicating a decrease of -100.00 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2026-03-27 2026-03-27 13G/A 6,712,443 0 -100.00 0.00 -100.00
2024-02-13 2024-02-13 13G/A 7,072,212 6,712,443 -5.09 10.47 3.36
2023-02-09 2023-02-09 13G/A 6,970,950 7,072,212 1.45 10.13 1.30
2022-07-11 2022-07-11 13G/A 6,800,195 6,970,950 2.51 10.00 2.15
2022-02-10 2022-02-10 13G/A 6,595,483 6,800,195 3.10 9.79 50.62
2021-02-10 2021-02-10 13G/A 6,806,939 6,595,483 -3.11 6.50 -3.27
2020-02-12 2020-02-12 13G/A 7,063,337 6,806,939 -3.63 6.72 -3.86
2019-02-11 2019-02-11 13G/A 7,161,282 7,063,337 -1.37 6.99 5.59
2018-02-09 2018-02-09 13G/A 6,665,663 7,161,282 7.44 6.62 7.99
2017-02-13 2017-02-13 13G/A 5,956,080 6,665,663 11.91 6.13 20.91
2017-02-13 2017-02-13 13G/A 5,956,080 6,665,663 11.91 6.13 20.91
2016-02-10 2016-02-10 13G 5,956,080 5.07

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F INNOVIVA COM 45781M101 7,917,103 819,757 11.55 158,263 22.19 0.0023
2025-11-07 2025-09-30 13F INNOVIVA COM 45781M101 7,097,346 -81,916 -1.14 129,527 -10.20 0.0019
2025-08-11 2025-06-30 13F INNOVIVA COM 45781M101 7,179,262 880,649 13.98 144,231 26.30 0.0023
2025-05-09 2025-03-31 13F INNOVIVA COM 45781M101 6,298,613 -14,018 -0.22 114,194 4.26 0.0021
2025-02-11 2024-12-31 13F INNOVIVA COM 45781M101 6,312,631 84,934 1.36 109,524 -8.92 0.0019
2024-11-13 2024-09-30 13F INNOVIVA COM 45781M101 6,227,697 47,247 0.76 120,257 18.64 0.0022
2024-08-13 2024-06-30 13F INNOVIVA COM 45781M101 6,180,450 -105,563 -1.68 101,359 5.80 0.0019
2024-05-10 2024-03-31 13F INNOVIVA COM 45781M101 6,286,013 5,490,464 690.15 95,799 2,874.17 0.0019
2024-03-11 2023-12-31 13F/A-1 THESEUS PHARMACEUTICALS COM 88369M101 795,549 6,429 0.81 3,222 51.79 0.0001
2024-03-11 2023-12-31 13F/A-1 INNOVIVA COM 45781M101 6,712,443 107,668
2024-02-14 2023-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 795,549 6,429 3,222 0.0001
2024-02-14 2023-12-31 13F INNOVIVA COM 45781M101 6,712,443 -4,994 107,668 0.0020
2023-12-18 2023-09-30 13F/A-1 THESEUS PHARMACEUTICALS COM 88369M101 789,120 57,695 7.89 2,123 -68.90 0.0001
2023-12-18 2023-09-30 13F/A-1 INNOVIVA COM 45781M101 6,717,437 -71,317 87,260 0.0021
2023-11-14 2023-09-30 13F THESEUS PHARMACEUTICALS COM 88369M101 789,120 57,695 2,123 0.0000
2023-11-14 2023-09-30 13F INNOVIVA COM 45781M101 6,717,437 -71,317 87,260 0.0004
2023-08-14 2023-06-30 13F THESEUS PHARMACEUTICALS COM 88369M101 731,425 30,464 4.35 6,824 9.64 0.0002
2023-08-14 2023-06-30 13F INNOVIVA COM 45781M101 6,788,754 -408,817 86,421 0.0020
2023-07-14 2023-03-31 13F/A-1 THESEUS PHARMACEUTICALS COM 88369M101 700,961 62,489 9.79 6,225 95.78 0.0002
2023-07-14 2023-03-31 13F/A-1 INNOVIVA COM 45781M101 7,197,571 125,359 80,973 0.0021
2023-05-15 2023-03-31 13F THESEUS PHARMACEUTICALS COM 88369M101 700,961 62,489 6,225 0.0000
2023-05-15 2023-03-31 13F INNOVIVA COM 45781M101 7,197,571 125,359 80,973 0.0004
2023-02-10 2022-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 638,472 12,529 2.00 3,180 -12.45 0.0001
2023-02-10 2022-12-31 13F INNOVIVA COM 45781M101 7,072,212 74,259 93,707 0.0026
2022-11-14 2022-09-30 13F THESEUS PHARMACEUTICALS COM 88369M101 625,943 -3,371 -0.54 3,631 4.31 0.0001
2022-11-14 2022-09-30 13F INNOVIVA COM 45781M101 6,997,953 27,003 81,247 0.0024
2022-08-12 2022-06-30 13F THESEUS PHARMACEUTICALS COM 88369M101 629,314 142,952 29.39 3,481 -37.93 0.0001
2022-08-12 2022-06-30 13F INNOVIVA COM 45781M101 6,970,950 147,560 102,890 0.0029
2022-05-13 2022-03-31 13F THESEUS PHARMACEUTICALS COM 88369M101 486,362 -396 -0.08 5,608 -9.14 0.0001
2022-05-13 2022-03-31 13F INNOVIVA COM 45781M101 6,823,390 23,195 132,032 0.0031
2022-02-14 2021-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 486,758 -6,212,962 -92.73 6,172 -94.49 0.0001
2022-02-14 2021-12-31 13F INNOVIVA COM 45781M101 6,800,195 100,475 117,303 0.0027
2021-11-12 2021-09-30 13F INNOVIVA COM 45781M101 6,699,720 -98,297 -1.45 111,953 22.81 0.0028
2021-08-13 2021-06-30 13F INNOVIVA COM 45781M101 6,798,017 30,566 0.45 91,163 12.73 0.0023
2021-05-14 2021-03-31 13F INNOVIVA COM 45781M101 6,767,451 171,968 2.61 80,871 -1.04 0.0022
2021-02-12 2020-12-31 13F INNOVIVA COM 45781M101 6,595,483 48,439 0.74 81,718 19.44 0.0024
2020-11-16 2020-09-30 13F INNOVIVA COM 45781M101 6,547,044 -276,438 -4.05 68,417 -28.28 0.0023
2020-08-14 2020-06-30 13F INNOVIVA COM 45781M101 6,823,482 20,571 0.30 95,392 19.24 0.0034
2020-05-15 2020-03-31 13F INNOVIVA COM 45781M101 6,802,911 -4,028 -0.06 80,003 -17.00 0.0034
2020-02-14 2019-12-31 13F INNOVIVA COM 45781M101 6,806,939 79,484 1.18 96,386 35.93 0.0033
2019-11-14 2019-09-30 13F INNOVIVA COM 45781M101 6,727,455 -383,278 -5.39 70,909 -31.51 0.0026
2019-08-14 2019-06-30 13F INNOVIVA COM 45781M101 7,110,733 19,426 0.27 103,532 4.06 0.0039
2019-05-15 2019-03-31 13F INNOVIVA COM 45781M101 7,091,307 27,970 0.40 99,491 -19.28 0.0039
2019-02-14 2018-12-31 13F INNOVIVA COM 45781M101 7,063,337 55,165 0.79 123,256 15.40 0.0055
2018-12-13 2018-09-30 13F/A-2 INNOVIVA COM 45781M101 7,008,172 157,136 2.29 106,804 12.97 0.0042
2018-11-23 2018-09-30 13F/A-1 INNOVIVA COM 45781M101 7,008,172 0 106,804 0.0042
2018-11-14 2018-09-30 13F INNOVIVA COM 45781M101 7,008,172 157,136 106,804
2018-08-14 2018-06-30 13F INNOVIVA COM 45781M101 6,851,036 -445,001 -6.10 94,545 -22.27 0.0040
2018-05-15 2018-03-31 13F INNOVIVA COM 45781M101 7,296,037 134,755 1.88 121,626 19.69 0.0053
2018-02-14 2017-12-31 13F INNOVIVA COM 45781M101 7,161,282 -175,049 -2.39 101,619 -1.90 0.0044
2017-11-14 2017-09-30 13F INNOVIVA COM 45781M101 7,336,331 -123,285 -1.65 103,588 8.49 0.0048
2017-08-24 2017-06-30 13F/A-1 INNOVIVA COM 45781M101 7,459,616 226,969 3.14 95,483 -4.54 0.0047
2017-08-11 2017-06-30 13F INNOVIVA COM 45781M101 7,459,616 226,969 95,483
2017-05-12 2017-03-31 13F INNOVIVA COM 45781M101 7,232,647 566,984 8.51 100,027 40.25 0.0051
2017-02-14 2016-12-31 13F INNOVIVA COM 45781M101 6,665,663 533,628 8.70 71,322 5.83 0.0040
2016-11-14 2016-09-30 13F INNOVIVA COM 45781M101 6,132,035 339,842 5.87 67,390 10.49 0.0040
2016-08-10 2016-06-30 13F INNOVIVA COM 45781M101 5,792,193 103,080 1.81 60,991 -14.85 0.0038
2016-05-13 2016-03-31 13F INNOVIVA COM 45781M101 5,689,113 -266,967 -4.48 71,626 14.10 0.0046
2016-02-08 2015-12-31 13F THERAVANCE COM 88338T104 5,956,080 141,703 2.44 62,777 50.38 0.0042
2015-11-12 2015-09-30 13F/A-1 THERAVANCE COM 88338T104 5,814,377 196,791 3.50 41,746 -58.87 0.0018
2015-08-13 2015-06-30 13F THERAVANCE COM 88338T104 5,617,586 148,435 2.71 101,509 18.07 0.0069
2015-05-15 2015-03-31 13F/A-1 THERAVANCE COM 88338T104 5,469,151 515,055 10.40 85,975 22.65 0.0058
2015-05-14 2015-03-31 13F THERAVANCE COM 88338T104 5,469,151 85,975
2015-02-12 2014-12-31 13F THERAVANCE COM 88338T104 4,954,096 105,234 2.17 70,100 -15.41 0.0050
2014-11-12 2014-09-30 13F THERAVANCE COM 88338T104 4,848,862 52,079 1.09 82,868 -41.99 0.0065
2014-08-11 2014-06-30 13F THERAVANCE COM 88338T104 4,796,783 128,742 2.76 142,847 -1.10 0.0113
2014-05-13 2014-03-31 13F THERAVANCE COM 88338T104 4,668,041 182,066 4.06 144,430 -9.69 0.0121
2014-02-12 2013-12-31 13F THERAVANCE COM 88338T104 4,485,975 337,142 8.13 159,925 -5.73 0.0141
2013-11-07 2013-09-30 13F THERAVANCE COM 88338T104 4,148,833 379,815 10.08 169,646 16.82 0.0166
2013-08-13 2013-06-30 13F THERAVANCE COM 88338T104 3,769,018 3,769,018 145,221 0.0153
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.